Viewing Study NCT01521702


Ignite Creation Date: 2025-12-25 @ 4:05 AM
Ignite Modification Date: 2026-05-31 @ 6:44 PM
Study NCT ID: NCT01521702
Status: COMPLETED
Last Update Posted: 2015-03-20
First Post: 2011-12-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic Cancer
Sponsor: Institut Paoli-Calmettes
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreas Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adenocarcinoma View
None pancreatic head View